Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
Editorial Group: Cochrane Gynaecological Cancer Group
Published Online: 16 JUN 2010
Assessed as up-to-date: 11 MAY 2010
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Galaal K, Naik R, Bristow RE, Patel A, Bryant A, Dickinson HO. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2010, Issue 6. Art. No.: CD007822. DOI: 10.1002/14651858.CD007822.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 16 JUN 2010
This article has been cited by:
- 1Ovarium- en tubacarcinoom, nieuwe ontwikkelingen, Huisarts en wetenschap, 2012, 55, 10, 460, ,
- 2Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer, European Journal of Surgical Oncology (EJSO), 2011, 37, 1, 4, , , , , , , , , ,